Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bezafibrate diminishes insulin resistance and improves lipid metabolism in hypertriglyceridemia

Sep. 1, 2003

New drug with potential in the management of preterm uterine activity

Sep. 1, 2003

BMS and Flamel enter Basulin agreement

Aug. 29, 2003

Estrogen receptor agonist as a potential new treatment for hot flush

Aug. 28, 2003

Synthetic progestins with high tissue and receptor selectivity

Aug. 27, 2003

TZE-5323: a potential therapeutic drug for the long-term treatment of endometriosis

Aug. 27, 2003

Boehringer Igelheim describes new glucocorticoid receptor modulators and their use

Aug. 27, 2003

Medtronic to commercialize rhBMP-2 in Japan

Aug. 27, 2003

Findings from DAC:GLP-1 studies reported

Aug. 27, 2003

NN-703 may be effective in adults with moderately severe GH deficiency

Aug. 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...